Abdominal Pain in Varicella Infection: Evaluation and Management
In patients with varicella infection presenting with abdominal pain, immediately obtain CT imaging to evaluate for visceral disseminated varicella zoster virus (VDVZV) infection and initiate empiric intravenous acyclovir without waiting for skin lesions to appear, as this life-threatening complication has a 55% mortality rate and abdominal pain typically precedes cutaneous manifestations by 1-10 days.
Clinical Recognition and Diagnostic Approach
Key Clinical Features to Identify
Abdominal pain in varicella represents a potential medical emergency requiring urgent evaluation. VDVZV should be suspected when patients present with:
- Severe, spontaneous abdominal pain (often epigastric or diffuse) without peritoneal signs 1, 2, 3
- Pain preceding skin lesions by 2-4 days in most cases, though cutaneous manifestations may never appear 1, 4
- Immunocompromised state (transplant recipients, chemotherapy, immunosuppressive therapy, prolonged lymphopenia) 3, 4
- Associated findings: hepatitis, pancreatitis, inappropriate ADH secretion, elevated transaminases/LDH, neutrophilia with thrombocytopenia 1, 5
Immediate Diagnostic Workup
CT imaging is the diagnostic modality of choice 6. Perform contrast-enhanced abdominal CT immediately, which may reveal:
- Periarterial fat stranding around celiac artery and superior mesenteric artery 2
- Pneumatosis intestinalis 5
- Enhanced periarterial inflammation without perforation or obstruction 1
Laboratory evaluation must include:
- VZV-DNA PCR from blood (most critical test - positive before skin lesions appear) 1, 5
- Liver enzymes, LDH, amylase/lipase
- Complete blood count (look for neutrophilia with thrombocytopenia)
- Blood cultures if patient appears toxic 7
The ACR Appropriateness Criteria support CT as the imaging modality of choice for acute nonlocalized abdominal pain with fever 6, which aligns perfectly with this clinical scenario.
Management Algorithm
Immediate Treatment (Do Not Delay)
1. Start IV acyclovir immediately upon clinical suspicion - do not wait for:
- Skin lesions to appear
- VZV-DNA results to return
- Definitive diagnosis
Dosing: 1500 mg/day (or 750 mg/day with renal adjustment) 3
2. Reduce or discontinue immunosuppressive therapy 1, 3
3. Consider IV immunoglobulin as adjunctive therapy 1
4. Fluid resuscitation per intra-abdominal infection guidelines - rapid restoration of intravascular volume 7
Antimicrobial Coverage Considerations
While the primary pathogen is VZV, if bacterial intra-abdominal infection cannot be excluded:
- Initiate empiric antibiotics covering enteric gram-negative bacilli and anaerobes 7
- Appropriate regimens include ticarcillin-clavulanate, ertapenem, or metronidazole plus ceftriaxone 7
- However, do not let this delay acyclovir initiation - the mortality from untreated VDVZV far exceeds typical bacterial infections
Surgical Consultation
Source control procedures are NOT indicated for VDVZV-related abdominal pain unless:
- True bacterial peritonitis with diffuse peritoneal signs develops 7
- Perforation or abscess is identified on imaging 7
The abdominal pain from VDVZV resolves rapidly with antiviral therapy alone 1, 2, 3.
Critical Pitfalls to Avoid
Most dangerous error: Waiting for skin lesions before initiating acyclovir. The delay in diagnosis when clinicians wait for cutaneous manifestations has resulted in fatal outcomes 4. Abdominal pain precedes rash by days in most cases, and some patients never develop skin lesions 4.
Second pitfall: Attributing abdominal pain to other causes (surgical abdomen, pancreatitis, mesenteric ischemia) and pursuing invasive interventions while missing VDVZV. The periarterial fat stranding on CT is characteristic 2.
Third pitfall: Inadequate acyclovir dosing or using oral formulations. IV therapy at full doses is essential given the high mortality rate 3.
Monitoring and Expected Course
With appropriate therapy:
- Abdominal pain resolves rapidly, typically within 24-48 hours 1, 2
- Skin lesions may appear after treatment initiation
- Complete recovery expected by day 14 of therapy 3
- Periarterial fat stranding on CT resolves as pain improves 2
Prophylaxis Considerations
In patients with prolonged lymphopenia (>4 months) or long-term steroid use undergoing chemotherapy, prophylactic acyclovir should be considered to prevent VDVZV 3. This is particularly relevant for lymphoma patients and transplant recipients where this complication is well-documented.